MedPath

Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial

Phase 3
Not yet recruiting
Conditions
Pregnancy Related
Registration Number
NCT06069856
Lead Sponsor
George Washington University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Attending first ANC visit at the study clinic<br><br> - Pregnant women = 15 weeks of gestation<br><br> - Aged = 18 years<br><br> - Intending to stay in the study area for the duration of study<br><br> - Provides informed consent<br><br>Exclusion Criteria:<br><br> - Severe anemia (defined as Hb <8.5 g/dL per Tanzania standard of care)<br><br> - Sickle cell disease (SS and SC) and hemoglobin C disease (CC) as tested by<br> HemoTypeSC<br><br> - Concurrent participation in other nutritional supplementation trial

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acceptability of formulation
Secondary Outcome Measures
NameTimeMethod
Most preferred formulation;Side Effects of formulation;Adherence
© Copyright 2025. All Rights Reserved by MedPath